ScholarIQanswers from OpenAlex
Prince of Songkla University
InstitutionResearch output, impact & collaborations
Prince of Songkla University is a institution indexed in ScholarIQ from OpenAlex.
What is known about Prince of Songkla University?
ScholarIQrecord summary
Prince of Songkla University is a research organisation in Songkhla, TH. OpenAlex records 33,798 works and 1,191,227 citations for it. 11,179 researchers list it as their most recent affiliation.
How many works does Prince of Songkla University have?
ScholarIQindexed works
Prince of Songkla University has 33,798 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Prince of Songkla University have?
ScholarIQcitation count
Prince of Songkla University has 1,191,227 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Prince of Songkla University?
ScholarIQresearcher count
Prince of Songkla University has 11,179 researchers in the ScholarIQ index.
What is the average h-index at Prince of Songkla University?
ScholarIQavg h-index
Prince of Songkla University has an average h-index of 76.5 in OpenAlex.
What is the ROR of Prince of Songkla University?
ScholarIQror
The ROR for Prince of Songkla University is on the source record.
What is the OpenAlex record for Prince of Songkla University?
ScholarIQopenalex
The OpenAlex for Prince of Songkla University is on the source record.
Who are the most-cited researchers behind Prince of Songkla University?
ScholarIQtop researchers by citations
What are the most-cited papers on Prince of Songkla University?
ScholarIQmost cited works
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
Lecia V. Sequist, James Chih‐Hsin Yang, Nobuyuki Yamamoto, Kenneth J. O’Byrne, Vera Hirsh, Tony Mok, Sarayut Lucien Geater, С. В. Орлов, Chun‐Ming Tsai, Michael Boyer, Wu‐Chou Su, Jaafar Bennouna, Terufumi Kato, В. А. Горбунова, Ki Hyeong Lee, Riyaz Shah, Dan Massey, Victoria Zazulina, Mehdi Shahidi, Martin Schüler
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
Yi‐Long Wu, Caicun Zhou, Chengping Hu, Jifeng Feng, Shun Lü, Yunchao Huang, Wěi Li, Mei Hou, Jian Hua Shi, Kye Young Lee, Chong‐Rui Xu, Dan Massey, Miyoung Kim, Yang Shi, Sarayut Lucien Geater
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
Roy S. Herbst, Giuseppe Giaccone, Filippo de Marinis, Niels Reinmuth, A. Vergnenègre, Carlos H. Barrios, Masahiro Morise, Enriqueta Felip, Zoran Andrić, Sarayut Lucien Geater, Mustafa Özgüroğlu, Wei Zou, Alan Sandler, Ida Enquist, Kimberly M. Komatsubara, Yu Deng, Hiroshi Kuriki, Xiaohui Wen, Mark L. McCleland, Simonetta Mocci, Jacek Jassem, David R. Spigel
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
James Chih‐Hsin Yang, Yi‐Long Wu, Martin Schüler, Martin Sebastian, Sanjay Popat, Nobuyuki Yamamoto, Caicun Zhou, Cheng-Ping Hu, Kenneth J. O’Byrne, Jifeng Feng, Shun Lü, Yunchao Huang, Sarayut Lucien Geater, Kye Young Lee, Chun-Ming Tsai, В. А. Горбунова, Vera Hirsh, Jaafar Bennouna, С. В. Орлов, Tony Mok, Michael Boyer, Wu‐Chou Su, Ki Hyeong Lee, Terufumi Kato, Dan Massey, Mehdi Shahidi, Victoria Zazulina, Lecia V. Sequist
First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
Jean‐Charles Soria, Daniel S.W. Tan, Rita Chiari, Yi‐Long Wu, Luis Paz‐Ares, Juergen Wolf, Sarayut Lucien Geater, С. В. Орлов, Diego Cortinovis, Chong‐Jen Yu, Maximillian Hochmair, Alexis B. Cortot, Chun‐Ming Tsai, Denis Moro‐Sibilot, Rosario García Campelo, Tracey McCulloch, Paramita Sen, Margaret Dugan, Serafino Pantano, Fabrice Branle, Cristian Massacesi, Gilberto de Castro
How much of the research on Prince of Songkla University is open access?
ScholarIQopen access share
38%OPEN ACCESS